PR PolyResearch

Join Free

NASDAQ

MediWound Ltd. - Ordinary Shares (MDWD)

♥ 549 Thanks from members

MediWound Ltd. (MDWD) shows polarized market sentiment; analysts maintain strong upside price targets near $30–$32 despite a temporary Q1 2026 revenue dip, fueled by the advancing Phase III VALUE trial for EscharEx and expanded NexoBrid manufacturing.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Other Nasdaq Tickers

GraniteShares 2x Long AAPL Daily ETF (AAPB)

Apple Inc. (AAPL)

Direxion Daily AAPL Bear 1X ETF (AAPD)

Ascentage Pharma Group International - American Depository Shares (AAPG)

Direxion Daily AAPL Bull 2X ETF (AAPU)

Rocket Pharmaceuticals, Inc. - Warrant (RCKTW)